Antibody validation for reproducible flow cytometry analysis [WEBINAR]
2.5 هزار بار بازدید -
5 سال پیش
-
For more information, visit
For more information, visit https://www.miltenyibiotec.com/lp/ant... Mona Al-Maarri highlights how Miltenyi Biotec’s antibody validation efforts improve quality and reproducibility in flow cytometry experiments. In this 30-minute webinar, you will learn about:
- The antibody-related reproducibility crisis
- Common causes of low reproducibility in flow cytometry experiments and lot-to-lot variations of
antibody reagents
- Recombinant antibodies and how they contribute to reproducibility
- Quality control and validation steps employed in Miltenyi Biotec´s antibody production
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,500 employees in over 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
- The antibody-related reproducibility crisis
- Common causes of low reproducibility in flow cytometry experiments and lot-to-lot variations of
antibody reagents
- Recombinant antibodies and how they contribute to reproducibility
- Quality control and validation steps employed in Miltenyi Biotec´s antibody production
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,500 employees in over 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
5 سال پیش
در تاریخ 1398/09/27 منتشر شده
است.
2,588
بـار بازدید شده